Table 4.
Marker | CVS-HTN |
CVS-NHTN |
P-value | ||||
---|---|---|---|---|---|---|---|
Median | IQR | Median | IQR | ||||
NEAT1 | 3.68 | 1.35 | 7.35 | 3.05 | 0.95 | 6.45 | 0.04a∗ |
<0.0001b∗ | |||||||
<0.000 c∗ | |||||||
HOTAIR | 0.13 | 0.04 | 0.81 | 0.34 | 0.04 | 0.71 | 0.05a∗ |
<0.001b∗ | |||||||
<0.000 c∗ | |||||||
GAS5 | 0.16 | 0.02 | 0.55 | 0.25 | 0.03 | 0.99 | 0.02a∗ |
<0.0001b∗ | |||||||
<0.000 c∗ |
Fold change levels of serum target non-coding RNA expressions relative to controls that were calculated using 2−ΔΔCT. Control fold change levels are equivalent to 1.
Comparison of cerebrovascular stroke in hypertensive patients versus cerebrovascular stroke in non-hypertensive patients.
Comparison of cerebrovascular stroke in non-hypertensive patients versus controls.
Comparison of cerebrovascular stroke in non-hypertensive patients versus controls.